Multiple Posts in Nectar Lifesciences | Require in FR&D, AR&D, QA, QC, CR&D, Production, Business Development
Nectar Lifesciences Ltd (NecLife) is a 200 million US$ integrated pharmaceutical organization, offering comprehensive range of Cephalosporin Active Pharmaceutical Ingredients and Finished Dosage Forms. The development and manufacture of quality intermediates, bulk actives have been critical to our success to become one of the largest manufacturers of cephalosporin range of products and delivering innovative and affordable products to domestic as well as international markets.
Indoco has built a visible presence across all it's markets in Europe, USA, Asia, Africa, Latin America and other CIS countries. A number of its products have emerged as brand leaders in the Indian and in International markets. Indoco has made significant investments to build capabilities in API manufacturing and R & D services to enhance its visibility.
Emcure are fortunate to have a very passionate and talented team. Emcure is committed to emerge as the most preferred 
Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.
